(Q43906669)

27 November 2017

Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients (English)

1 reference

27 November 2017

0 references

1 reference

1

1 reference

27 November 2017

Vargas V

2

1 reference

27 November 2017

Heydari N

3

1 reference

27 November 2017

Kümpfel T

4

1 reference

27 November 2017

Meinl E

5

1 reference

27 November 2017

Hohlfeld R

6

1 reference

27 November 2017

1 February 2002

1 reference

Journal of Neuroimmunology

27 November 2017

1 reference

27 November 2017

123

1 reference

27 November 2017

1-2

1 reference

27 November 2017

188-192

1 reference

New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

Nerve growth factor specifically induces human IgG4 production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900490-8

7 January 2021

10.1016/S0165-5728(01)00490-8

Identifiers

DOI

1 reference

27 November 2017

1 reference